Literature DB >> 7607569

Double-differential PCR for gene dosage estimation of erbB oncogenes in benign and cancer tissues and comparison to cellular DNA content.

B Brandt1, U Vogt, F Harms, U Bosse, K S Zänker, G Assmann.   

Abstract

Competitive and differential quantitative PCR methods circumvent the limiting factors of PCR which cause poor reproducibility. We describe the development and performance evaluation of another quantitative PCR method, double-differential PCR (ddPCR). The ddPCR method comprises the co-amplification of the single-copy gene HBB, the erbB-1, erbB-2 and erbB-3 oncogenes and the second single-copy reference gene SOD2 under equal reaction conditions. The ratio of band intensities of the PCR products in silver-stained polyacrylamide gels expresses the average gene copy number (AGCN) per cell of the erbB oncogenes. The coefficient of variability (CV) was less than 25% for an AGCN of 1. The PCR data were in correlation to the results from dot blotting. DNA image analysis did not reveal any correlation between DNA content and gene dosage deviation of the erbB oncogenes. The method was applied to normal breast tissue, benign breast diseases, breast cancer tissue and lymph node metastases. We suggest this method as being reproducible, low cost and rapid, and therefore suitable for clinical studies on erbB oncogene dosage estimation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607569     DOI: 10.1016/0378-1119(94)00651-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Detection of the metastatic potential of blood-borne and immunomagnetically enriched epithelial cells by quantitative erbB-2 RT-PCR.

Authors:  B Brandt; C Griwatz; S Heidl; G Assmann; K S Zänker
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

2.  Genetic characterisation of invasive breast cancer: a comparison of CGH and PCR based multiplex microsatellite analysis.

Authors:  H Buerger; H Schmidt; A Beckmann; K S Zänker; W Boecker; B Brandt
Journal:  J Clin Pathol       Date:  2001-11       Impact factor: 3.411

3.  Determination of copy number of rRNA genes in Pneumocystis carinii f. sp. hominis.

Authors:  X Tang; M S Bartlett; J W Smith; J J Lu; C H Lee
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

4.  Gene copy numbers of HER family in breast cancer.

Authors:  Anna Zaczek; Marzena Wełnicka-Jaśkiewicz; Krzysztof Piotr Bielawski; Janusz Jaśkiewicz; Andrzej Badzio; Włodzimierz Olszewski; Piotr Rhone; Jacek Jassem
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-28       Impact factor: 4.553

5.  Quantitative Analysis of ErbB1 and ErbB2 Genes Amplification by a High Performance Liquid Chromatography.

Authors:  Mozhgan Rasti; Zohreh Honardar; Mohsen Nikseresht; Aliakbar Owji
Journal:  Avicenna J Med Biotechnol       Date:  2014-10

6.  Applying microsatellite multiplex PCR analysis (MMPA) for determining allele copy-number status and percentage of normal cells within tumors.

Authors:  Carles Garcia-Linares; Jaume Mercadé; Bernat Gel; Josep Biayna; Ernest Terribas; Conxi Lázaro; Eduard Serra
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

7.  C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer.

Authors:  Claus M Schlotter; Ulf Vogt; Ulrich Bosse; Berthold Mersch; Katja Wassmann
Journal:  Breast Cancer Res       Date:  2003-01-13       Impact factor: 6.466

8.  c-myc, not her-2/neu, can predict the prognosis of breast cancer patients: how novel, how accurate, and how significant?

Authors:  Fernando C Schmitt; Jorge S Reis-Filho
Journal:  Breast Cancer Res       Date:  2003-04-24       Impact factor: 6.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.